Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

EXPLAINED: 14 - The Real Truth

Push for raw milk intensifies across the US, despite illness outbreaks and scientists' warnings

Proponents of raw milk are pushing to make the unpasteurized product more widely available and easy to obtain

The Independent UK

Why Studying the Finished Formulation Matters More Than Ingredient Lists

For anyone evaluating a finished formulation, understanding that regulatory context changes how you read an ingredient list.

Medical Daily

Trump may finally make it illegal to shock autistic kids as punishment – after kicking the issue down the road

Use of electrical stimulation devices to prevent ‘self-injurious or aggressive behaviors’ widely opposed, with experts expressing concern over long-term physical and mental consequences

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Nationwide Cantaloupe Recall What Shoppers Need to Know About Salmonella

Food safety is a critical concern for families loading up their grocery carts with fresh produce this spring. Federal health agencies recently issued a severe warning regarding a popular fruit sold at major national supermarkets. A dangerous bacterial outbreak is currently sweeping across the supply chain and causing severe illness…

Grocery Coupon Guide

Make America Healthy Again? Tobacco Executive Stephen Sayle Appointed to a Senior Leadership Role at the CDC

Stephen Sayle, a former tobacco executive, has been appointed as CDC deputy director for legislative affairs, sparking concerns about industry influence in public health policy.

International Business Times UK

Should You Buy HIMS Stock Following Friday's Rally?

Hims & Hers stock rallied on Friday on a major regulatory update and bullish analyst note. Here’s how high HIMS shares could realistically fly through the end of 2026.

Barchart

Trump Officially Flipped the Script on the War on Drugs, Issues Bold Orders on Marijuana and Psychedelics

Donald Trump has ordered fast-tracked research into psychedelics and moved to reschedule medical marijuana, signalling a sharp shift in Republican drug policy.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

The FDA Fast-Tracks Its Review of Psilocybin and Methylone, 2 Promising Psychedelics

The agency issued "national priority vouchers" for the two drugs six days after President Donald Trump promised to facilitate approval of psychedelic therapies.

Reason

Trail mix sold at Meijer in six states under recall for allergy risk

Trail mix containing two of the nine ‘major allergens’ has been removed from stores across six states

The Independent UK

FDA expedites review of three psychedelic drugs after Trump order

IN FULL

The Independent UK

Three psychedelic drugs to undergo ‘ultra-fast’ FDA review after Trump order

The recent moves reflect growing support for the mind-altering substances among Trump’s supporters

The Independent UK

Trump psychedelics order largely symbolic, analysts say

Executive order to speed access to psychedelic treatments likely to have limited legal impact despite high-profile push

The Guardian - US

'A landmark moment for the field': FDA approves first-ever gene therapy for inherited deafness

A gene therapy made by Regeneron is the first treatment of its kind approved for genetic hearing loss.

LiveScience

Marijuana Rescheduled

Plus: skyway socialism, reconsider the lobster, D.C.'s urban growth, and more...

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

‘Can I have some, please?’: has Trump opened the door to a psychedelic future?

Order to speed hallucinogen research hailed as ‘threshold moment’ but concerns remain over access and protections

Axios

RFK Jr.'s peptide push could become next wellness boom

The heavily touted but loosely regulated proteins could fuel the kind of boom we've seen with weight-loss drugs.

inkl

Remote Patient Monitoring vs Chronic Care Management vs RTM: What’s the Difference?

The healthcare industry is rapidly evolving, and digital health solutions are at the forefront of this transformation.

LiveScience

Gene therapy improves hearing in 90% of patients with inherited deafness in largest trial of its kind

A new gene therapy tested in China has improved the hearing of 38 people who were born deaf due to mutations in a gene called OTOF.

Get all your
news in one place.

100's of premium titles.
One news app.

Reason

Trump's Embrace of Psychedelic Therapy Leaves Most Users on the Wrong Side of the Law

The medical model assumes that people should be allowed to use psychedelics only for government-approved reasons.

The Independent UK

Cantaloupe recall upgraded in US over potentially deadly contamination concerns

Recalled fruit was distributed to retailers in four states

Reason

The COVID Reckoning Doesn't Go Far Enough

Real medical freedom will require something greater than replacing the public health establishment: ending the FDA's monopoly.

Barchart

Jazz Pharmaceuticals Stock, a Barchart Favorite, Trends Higher as Trump Renews Cannabis Hopes. Should You Buy JAZZ Here?

Jazz Pharmaceuticals stock pops as President Trump signals renewed urgency to reclassify cannabis as Schedule III drug. Technicals signal further upside ahead in JAZZ shares.

Reason

The Promise and Limits of Trump's Psychedelic Therapy Order

The president's facilitation of research and FDA review could help make psychedelics available to approved patients. But what about everyone else?

MarketBeat

This 4/20, Wall Street Is Betting on More Than Marijuana

Wall Street is currently pivoting toward high-growth biotech plays as federal support accelerates a revolution in alternative medicine.

Barchart

Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here?

Compass Pathways stock rallies as Trump’s new executive order aims at accelerating approval and research of psychedelic medicines. But is it too late to invest in CMPS shares already?

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

214 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.